VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 189 filers reported holding VERACYTE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,320,619 | -4.0% | 59,141 | +9.4% | 0.00% | 0.0% |
Q2 2023 | $1,376,271 | -25.2% | 54,035 | -34.5% | 0.00% | -33.3% |
Q1 2023 | $1,839,193 | +39.5% | 82,475 | +48.5% | 0.00% | +50.0% |
Q4 2022 | $1,318,344 | -99.9% | 55,556 | -56.2% | 0.00% | -33.3% |
Q3 2022 | $2,103,801,000 | +484.1% | 126,735 | +600.2% | 0.00% | +200.0% |
Q2 2022 | $360,190,000 | +11.7% | 18,100 | +54.8% | 0.00% | – |
Q1 2022 | $322,431,000 | -69.9% | 11,695 | -55.0% | 0.00% | -100.0% |
Q4 2021 | $1,069,758,000 | +34.3% | 25,965 | +51.4% | 0.00% | +100.0% |
Q3 2021 | $796,803,000 | +705.3% | 17,154 | +593.1% | 0.00% | – |
Q2 2021 | $98,951,000 | -77.5% | 2,475 | -69.7% | 0.00% | -100.0% |
Q1 2021 | $438,869,000 | -62.4% | 8,165 | -65.7% | 0.00% | -50.0% |
Q4 2020 | $1,166,583,000 | -11.5% | 23,837 | -41.3% | 0.00% | 0.0% |
Q3 2020 | $1,318,607,000 | +37.7% | 40,585 | +9.8% | 0.00% | 0.0% |
Q2 2020 | $957,394,000 | -30.6% | 36,965 | -34.9% | 0.00% | -33.3% |
Q1 2020 | $1,379,787,000 | +91.0% | 56,758 | +119.4% | 0.00% | +200.0% |
Q4 2019 | $722,346,000 | +18.2% | 25,872 | +1.6% | 0.00% | 0.0% |
Q3 2019 | $611,280,000 | +582.6% | 25,470 | +710.9% | 0.00% | – |
Q2 2019 | $89,550,000 | -39.2% | 3,141 | -46.7% | 0.00% | – |
Q1 2019 | $147,318,000 | +130269.9% | 5,888 | +65322.2% | 0.00% | – |
Q4 2018 | $113,000 | -98.3% | 9 | -98.7% | 0.00% | – |
Q3 2018 | $6,695,000 | +2.3% | 701 | 0.0% | 0.00% | – |
Q2 2018 | $6,547,000 | -76.6% | 701 | -86.1% | 0.00% | – |
Q1 2018 | $28,017,000 | -7.4% | 5,039 | +8.8% | 0.00% | – |
Q4 2017 | $30,253,000 | +44.0% | 4,633 | +93.4% | 0.00% | – |
Q3 2017 | $21,004,000 | +3.0% | 2,395 | -2.2% | 0.00% | – |
Q2 2017 | $20,392,000 | +185.2% | 2,448 | +214.2% | 0.00% | – |
Q1 2017 | $7,151,000 | -43.1% | 779 | -52.0% | 0.00% | – |
Q4 2016 | $12,570,000 | +72.8% | 1,624 | +69.9% | 0.00% | – |
Q3 2016 | $7,275,000 | +159.2% | 956 | +71.3% | 0.00% | – |
Q2 2016 | $2,807,000 | -87.4% | 558 | -81.9% | 0.00% | – |
Q4 2015 | $22,204,000 | +56.0% | 3,084 | +1.6% | 0.00% | – |
Q3 2015 | $14,234,000 | +13.9% | 3,035 | +170.5% | 0.00% | – |
Q2 2015 | $12,499,000 | +1092.7% | 1,122 | +679.2% | 0.00% | – |
Q1 2015 | $1,048,000 | +95.5% | 144 | +161.8% | 0.00% | – |
Q3 2014 | $536,000 | – | 55 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |